Introduction Semaglutide is revolutionizing the management of type 2 diabetes, obesity, and heart health. This medication, a member of the GLP-1 receptor agonist class, works by mimicking the effects of GLP-1, a hormone naturally produced by the body to help regulate blood sugar, insulin secretion, and appetite. Initially developed to https://israeltupgb.wikisona.com/1118462/semaglutide_a_breakthrough_in_managing_diabetes_obesity_and_cardiovascular_health